Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.

MLA

Hoshino, S., et al. “Activation via the CD3 and CD16 Pathway Mediates Interleukin-2-Dependent Autocrine Proliferation of Granular Lymphocytes in Patients with Granular Lymphocyte Proliferative Disorders.” Blood, vol. 78, no. 12, Dec. 1991, pp. 3232–40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1835892&authtype=sso&custid=ns315887.

APA

Hoshino, S., Oshimi, K., Teramura, M., & Mizoguchi, H. (1991). Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders. Blood, 78(12), 3232–3240.

Chicago

Hoshino, S, K Oshimi, M Teramura, and H Mizoguchi. 1991. “Activation via the CD3 and CD16 Pathway Mediates Interleukin-2-Dependent Autocrine Proliferation of Granular Lymphocytes in Patients with Granular Lymphocyte Proliferative Disorders.” Blood 78 (12): 3232–40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1835892&authtype=sso&custid=ns315887.